Inventor
Ramachandran Murali
Inventor
Drexel Hill, PA, US
Overview
Patents· 42 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07KPeptides18%
C07DHeterocyclic compounds6%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
C07CAcyclic or carbocyclic compounds5%
A61NElectrotherapy2%
C07BGeneral methods of organic chemistry1%
C12NMicroorganisms or enzymes1%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
PatentTitleYear
10,927,070Compositions and methods for treating cancer202110,881,641Methods and use of compounds that bind to RelA of NF-kB202110,836,735Compositions and methods for treating cancers202010,583,166Antigen-binding proteins comprising recombinant protein scaffolds202010,266,505Compositions and methods for treating cancers201910,245,298Compositions and methods for treating fibrosis201910,029,997Compositions and methods for treating cancers20189,751,830'Inhibitors of the tumor necrosis factor receptor complex'20179,695,252'Antigen-binding proteins comprising recombinant protein scaffolds'20179,265,739'Methods and use of compounds that bind to HER2/neu receptor complex'20169,096,607'Tumor necrosis factor inhibitors'20158,993,634'Methods and use of compounds that bind to Her2/neu receptor complex'20158,962,793'ErbB interface peptidomimetics and methods of use thereof'20158,859,503'Methods and compositions targeting viral and cellular ITAM motifs, and use of same in identifying compounds with therapeutic activity'20148,785,419'Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same'20148,765,810'Tumor necrosis factor inhibitors'20148,728,479'Antigen-binding proteins comprising recombinant protein scaffolds'20148,710,068'Method of treating cancer using a survivin inhibitor'20148,680,047'Fas peptide mimetics and uses thereof'20148,609,730'Rel inhibitors and methods of use thereof'20138,445,644'ErbB interface peptidomimetics and methods of use thereof'20138,318,699'Tumor necrosis factor inhibitors'20128,057,799'ErbB interface peptidomimetics and methods of use thereof'20118,022,176'FAS peptide mimetics and uses thereof'20118,019,557'Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same'20118,003,628'Methods of inhibiting osteoclast activity'20117,998,924'Compounds that bind to p185 and methods of using the same'20117,906,624'Binding peptidomimetics and uses of the same'20117,781,566'ErbB interface peptidomimetics and methods of use thereof'20107,745,577'Compounds that bind to P185 and methods of using the same'20107,662,374'Monoclonal antibodies to activated erbB family members and methods of use thereof'20107,653,495'Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same'20107,638,598'ErbB interface peptidomimetics and methods of use thereof'20097,625,558'Compositions and methods of treating tumors'20097,566,741'Methods of inhibiting osteoclast activity'20097,288,519'Fas peptide mimetics and uses thereof'20077,179,785'Compounds that bind to p185 and methods of using the same'20076,740,665'Tyrosine kinase inhibitors and methods of using the same'20046,682,739'Methods of inhibiting osteoclastogenesis'20046,673,771'Methods of inhibiting osteoclast activity'20046,417,168'Compositions and methods of treating tumors'20026,265,535'Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2020Patents assigned to UNIV PENNSYLVANIA (35)· patent assignee history
2001–2015Based in Drexel Hill, PA, US· patent location history
2007–2020Based in Swarthmore, PA, US· patent location history
2007Based in Swartmore, PA, US· patent location history
2011–2017Patents assigned to MURALI RAMACHANDRAN (12)· patent assignee history
2011–2017Patents assigned to GREENE MARK I (10)· patent assignee history
2011–2016Patents assigned to ZHANG HONGTAO (5)· patent assignee history
2014–2021Based in Beverly Hills, CA, US· patent location history
2014Based in Los Angeles, CA, US· patent location history
2018–2021Patents assigned to CEDARS SINAI MEDICAL CENTER (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV PENNSYLVANIA | 35 | 2001–2020 |
| MURALI RAMACHANDRANself | 12 | 2011–2017 |
| GREENE MARK I | 10 | 2011–2017 |
| CEDARS SINAI MEDICAL CENTER | 6 | 2018–2021 |
| ZHANG HONGTAO | 5 | 2011–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Drexel Hill, Pennsylvania, US | 18 | 2001–2015 |
| Swarthmore, Pennsylvania, US | 13 | 2007–2020 |
| Beverly Hills, California, US | 9 | 2014–2021 |
| Los Angeles, California, US | 1 | 2014 |
| Swartmore, Pennsylvania, US | 1 | 2007 |